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Introduction
Coronary artery disease (CAD) is a major cause of death among 
postmenopausal women [1]. As time from the onset of meno-
pause is closely related to the onset of coronary atherosclerosis, 
the prevalence of CAD has risen in tandem with increased life 
expectancy. As a result, the number of postmenopausal women 
who suffer from CAD is expected to increase over time. There-
fore, identifying the risk factors associated with CAD in post-
menopausal women is critical for reducing related mortality, along 
with associated healthcare costs.
Previous studies have demonstrated that osteoporosis and ath-
erosclerosis have common etiological factors and mechanisms, 
suggesting that the presence of osteoporosis is a predictor of 
atherosclerosis [2-4]. According to recent studies, decreased bone 
mineral density (BMD) is associated with vascular calcification, 
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which has been found to be a predictor of overall CAD incidence 
and mortality. Furthermore, several prospective studies have 
reported that low BMD and bone loss are risk factors for CAD-
related mortality [5-7].
We have previously reported that values of brachial-ankle pulse 
wave velocity, an indicator of arterial stiffness, were significantly 
higher in an osteoporosis group (compared to osteopenia and 
normal BMD groups), and that these values were negatively as-
sociated with BMD [8]. These findings indicate that decreased 
BMD may increase the risk of developing coronary atherosclerosis. 
However, little is known about the association between decreased 
BMD and coronary atherosclerosis in postmenopausal woman; 
therefore, we chose to investigate the association between BMD 
and coronary atherosclerosis in healthy postmenopausal women.
Materials and methods 
1. Participants
The study was approved by the institutional review board of Sev-
erance Hospital, Yonsei University College of Medicine. We per-
formed a retrospective review of postmenopausal women who 
had visited the health promotion center at Gangnam Severance 
Hospital, Seoul, Korea for a routine checkup from March 2007 
to December 2009. Body weight and height were measured in 
light indoor clothing, and body mass index (BMI) was calculated 
as weight (kg) divided by height squared (m2). Blood pressure 
was assessed in the sitting position, after 10 minutes of rest, us-
ing an automated device (TM-2665P, A&D Co., Tokyo, Japan). All 
participants underwent dual-energy X-ray absorptiometry (DEXA) 
and 64-row multidetector computed tomography (64-MDCT) as 
part of the routine checkup.
We included postmenopausal women over 45-years-old, with 
menopause defined as 12 months of amenorrhea, subsequently 
confirmed by serum follicle-stimulating hormone levels >30 mIU/
mL. Exclusion criteria included current smoking status, hyperten-
sion, diabetes mellitus, hypercholesterolemia, and cardiovascular 
disease. Participants who were receiving menopausal hormone 
therapy (MHT) or medication that might directly affect BMD 
were also excluded. A total of 252 participants who satisfied 
these criteria were included in the study analysis.
Physical activity was divided into two categories. Active exer-
cise was defined as exercising three or more times per week for 
over 30 minutes. Alcohol intake was divided into two categories: 
those who consumed alcohol and those who did not.
2.  Bone mineral density measurement
Areal BMD (g/cm2) was assessed using DEXA (QDR-Delphi; 
Hologic, Bedford, MA, USA) in the lumbar spine (L1–L4) and 
femoral neck. Participants were divided into normal BMD and 
osteopenia-osteoporosis groups, according to the T-scores of 
their lumbar spine and femur neck. Normal BMD, osteopenia, 
and osteoporosis were defined according to the World Health 
Organization’s criteria. Osteoporosis was defined as bone den-
sity 2.5 or more standard deviations (SD) below the young adult 
mean (-2.5 SD or lower), and osteopenia was defined as bone 
density between 1 and 2.5 SD below the young adult mean (-1 
to -2.5 SD) [9].
3.  Coronary artery assessment
Cardiac computed tomography was performed using a 64-
MDCT scanner (Philips Brilliance 64, Philips Medical System, 
Best, Netherlands). A β-blocker (40–80 mg of propranolol 
hydrochloride; Pranol, Dae Woong, Seoul, Korea) was admin-
istered orally 1 hour before the scan, to decrease the heart 
rate of women with a heart rate of ≥70 beats/min. Image 
reconstruction was performed on the scanner’s workstation 
using commercially available software (Extended Brilliance 
Workstation, Philips Medical System). Coronary atherosclero-
sis was defined as any size of calcified, or non-calcified, ath-
erosclerotic plaque with luminal narrowing.
4.  Statistical analysis
Results were expressed as the mean±SD. The two-sample t-
test was used to compare means of continuous variables, and 
the χ2-test was used to compare proportions of categorical 
variables. Logistic regression analysis was conducted to exam-
ine associations between decreased BMD and coronary ath-
erosclerosis. Analyses were adjusted for age, alcohol intake, 
exercise, and vascular risk factors, which included BMI, fast-
ing glucose levels, systolic blood pressure, and high-density 
lipoprotein (HDL) cholesterol levels.
All statistical analyses were conducted using SPSS ver. 15.0 
(SPSS Inc., Chicago, IL, USA). A P-value less than 0.05 was 
considered to be of statistical significance.
Results 
The average clinical and laboratory results for all participants are 
listed in Table 1. Age was significantly higher, and BMI was sig-
nificantly lower, among women with osteopenia-osteoporosis 
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compared to women with normal BMD. BMD values for the lum-
bar spine in the normal and osteopenia-osteoporosis groups were 
1.01±0.09 and 0.85±0.10 g/cm2 respectively. BMD values for the 
femoral neck in the normal and osteopenia-osteoporosis groups 
were 0.77±0.06 and 0.62±0.07 g/cm2 respectively (Table 1).
Fig. 1 shows the proportion of coronary atherosclerosis in the 
normal BMD and osteopenia-osteoporosis groups. Participants 
with osteopenia-osteoporosis had a significantly higher propor-
tion of coronary atherosclerosis at the lumbar spine (P=0.003) 
and femoral neck (P=0.004), when compared to those with 
normal BMD.
Multiple regression analysis was performed to investigate the 
association between decreased BMD and coronary atheroscle-
rosis. Osteopenia-osteoporosis at the lumbar spine (odds ratio 
[OR], 2.855; 95% confidence interval [CI], 1.121 to 7.23) and 
femoral neck (OR, 3.354; 95% CI, 1.065 to 10.569) was associ-
ated with coronary atherosclerosis, after controlling for age and 
vascular risk factors (Table 2).
Discussion
The present study revealed that decreased BMD was signifi-
cantly associated with coronary atherosclerosis, independent 
of other risk factors. These findings suggest that postmeno-
pausal women with decreased BMD may have a higher risk 
of developing coronary atherosclerosis. Our results confirmed 
a significant relationship between osteoporosis and coronary 
atherosclerosis, as previous studies have suggested, as well as a 
relationship between osteopenia and coronary atherosclerosis.
Menopause is a natural aging process, characterized by a 
decrease in estrogen and an increase in ferritin levels, during 
which a woman passes from her reproductive to non-repro-
ductive years [10]. Estrogen deficiency impairs the normal bone 
remodeling cycle by increasing osteoclast resorption activity, 
without a corresponding increase in osteoblast activity, result-
ing in a net loss of bone [11]. Free iron deposits in tissues also 
create a pathological condition (iron overload), which impairs 
bone remodeling by inhibiting osteoblast proliferation and dif-
ferentiation [12]. Meanwhile, it is well known that estrogen 
prevents the development of atherosclerosis, and that risk of 
CAD increases for postmenopausal women. In addition, excess 
iron in the tissues may catalyze the formation of highly reactive 
oxygen free radicals, which can trigger the development of ath-
erosclerosis. Our previous study has shown that ferritin levels 
were associated with an increased risk of subclinical coronary 
atherosclerosis in postmenopausal women [13]. These facts 
suggest that decreased BMD may be associated with coronary 
atherosclerosis, especially in postmenopausal woman.
In postmenopausal women, osteoporosis and CAD are major 
causes of morbidity and mortality. Although MHT has been 
used to prevent these two diseases, MHT is no longer recom-
Table 1. Clinical and laboratory characteristics of participants
Variables Normal BMD (n=75) Osteopenia-osteoporosis (n=177) P-value
Age (yr) 53.5±4.4 56.2±6.1 <0.001
Body mass index (kg/m2) 23.0±2.5 21.9±2.3 0.002
Systolic blood pressure (mmHg) 119.2±16.0 116.7±16.6 0.207
Diastolic blood pressure (mmHg) 73.9±10.0 72.2±9.8 0.189
Follicle-stimulating hormone (mIU/mL) 79.7±27.3 81.4±23.8 0.677
Estradiol (pg/mL) 11.6±13.6 9.6±7.8 0.230
Total cholesterol (mg/dL) 204.6±28.0 203.7±33.5 0.828
LDL-cholesterol (mg/dL) 130.7±28.7 128.7±31.1 0.643
HDL-cholesterol (mg/dL) 58.6±13.0 57.2±13.4 0.454
Triglyceride (mg/dL) 91.3±46.4 101.5±62.8 0.155
Fasting glucose (mg/dL) 92.0±9.9 89.9±9.6 0.135
C-reactive protein (mg/dL) 1.1±1.6 1.4±2.6 0.293
Uric acid (mg/dL) 4.4±0.8 4.4±0.9 0.578
Lumbar spine (L1–L4) BMD (g/cm2) 1.01±0.09 0.85±0.10 <0.001
Femoral neck BMD (g/cm2) 0.77±0.06 0.62±0.07 <0.001
BMD, bone mineral density; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
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mended as a first-line therapy for osteoporosis and CAD. There-
fore, identification of individual with a high risk of the diseases 
is important for the prevention. As estrogen deficiency and iron 
overload in the postmenopausal period are common risk fac-
tors for both osteoporosis and CAD, measuring BMD may be 
a useful screening tool for identifying postmenopausal women 
with high-risk of developing osteoporotic fractures or CAD.
The key pathological step in atherosclerosis is thought 
to be the formation of calcified plaque on the endothelial 
surface. However, the results from previous studies are in 
disagreement regarding whether osteoporosis truly influ-
ences vascular calcification. In contrast to our results, some 
authors have indicated that there is no relationship between 
osteoporosis and atherosclerosis [14,15]. In another study, 
osteoporosis and coronary atherosclerosis were found to be 
independent processes in postmenopausal women, after 
adjusting for age, smoking status, diabetes mellitus, hyper-
tension, and hypercholesterolemia [16]. However, other re-
searchers have found that cardiovascular mortality is higher 
in women with low BMD [6]. Recent studies have also found 
that atherosclerotic calcification is associated with bone loss 
in postmenopausal women [17,18], and that a decrease in 
BMD may be related to subclinical atherosclerosis [7,19-21]. 
The mechanisms explaining the relationship between osteo-
porosis and CAD have not yet been elucidated, though it is 
believed that many other factors may be responsible; these 
factors have yet to be investigated.
We attempted to investigate the association between 
BMD and coronary atherosclerosis using 64-MDCT, which 
can accurately detect coronary atherosclerosis, even in as-
ymptomatic individuals. Reported sensitivity and specificity 
of 64-MDCT range from 85% to 99% and 86% to 96%, 
respectively [22-25]. 64-MDCT has also improved the detec-
tion of non-calcified plaques, which, compared to calcified 
plaques, are considered more likely to be unstable and vul-
nerable to sudden rupture, subsequently increasing the risk 
of fatal ischemic cardiac events [26,27]. In another study, a 
considerable proportion of non-calcified plaques were found 
in asymptomatic low-risk patients with no, or mild, coronary 
calcium [28]. Moreover, we included only healthy postmeno-
pausal women by excluding participants with a medical 
history of hypertension, diabetes mellitus, hypercholester-
olemia, or cardiovascular disease. Therefore, correlation be-
tween BMD and CAD in previous studies and our study BMD 
is a considerable screening method for coronary atheroscle-
rosis in healthy postmenopausal women, thereby facilitating 
early treatment and better outcomes.
Although our results are encouraging, the retrospective 
nature of the study precludes the possibility of investigating 
Table 2. Logistic regression analysis of association between osteopenia-osteoporosis and atherosclerosis
OR 95% CI P-value OR 95% CI P-value
Age (yr) 1.117 1.043–1.197 0.002 1.113 1.039–1.193 0.002
Body mass index (kg/m2) 0.892 0.737–1.080 0.240 0.906 0.745–1.102 0.323
Systolic blood pressure (mmHg) 1.016 0.991–1.042 0.205 1.015 0.989–1.041 0.259
Fasting glucose (mg/dL) 1.028 0.983–1.074 0.225 1.029 0.985–1.076 0.201
HDL-cholesterol (mg/dL) 0.995 0.962–1.028 0.401 0.994 0.961–1.028 0.724
Decreased lumbar spine (L1–L4) BMD 2.855 1.121–7.273 0.028 - - -
Decreased femoral neck BMD - - - 3.354 1.065–10.569 0.039
Adjusted for age, alcohol intake, exercise, and vascular risk factors, including body mass index, systolic blood pressure, fasting 
glucose, and HDL-cholesterol.
OR, odds ratio; CI, confidence interval; HDL, high-density lipoprotein; BMD, bone mineral density.
Fig. 1. Distribution of CA (-) and CA (+) patients in normal and osteopenia-
osteoporosis groups. CA, coronary atherosclerosis; BMD, bone mineral density.
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the causal relationship between bone loss and coronary ath-
erosclerosis. In addition, our hospital-based design, and the 
limited number of participants, restricted our ability to reach 
a precise conclusion regarding the association between bone 
loss and coronary atherosclerosis. Larger longitudinal studies 
would likely be required to fully investigate the effects of bone 
loss on coronary atherosclerosis in postmenopausal women 
and clarify BMD is reliable screening method for CAD.
In conclusion, our results demonstrate that decreased BMD is 
associated with coronary atherosclerosis in healthy postmeno-
pausal women, independent of age and cardiovascular risk 
factors. Therefore, postmenopausal women with low BMD may 
have a higher risk of developing coronary atherosclerosis.
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